Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway

Immunological Reviews
A von BoninB Fleischer

Abstract

CD26 is a proteolytic enzyme (dipeptidyl-peptidase IV) with a wide tissue distribution and a unique specificity that was already described 27 years ago. CD26 is expressed on a fraction of resting T cells at low density but is strongly upregulated following T-cell activation. Recent results indicate that CD26 is a multifunctional molecule that may have important functions on T cells and in the immune system. It is associated with molecules of immunological importance such as the protein tyrosine phosphatase CD45 and adenosine deaminase (ADA) on the cell surface. Synthetic inhibitors of the enzymatic activity of CD26 have been shown to suppress certain immune reactions in vitro and in vivo. An interesting feature of CD26 is its ability to transmit a transmembrane signal to trigger functional programs in T cells. This triggering requires crosslinking of CD26 on a cell membrane. The enzymatic activity of CD26 is not obligatory for the activation of T cells via CD26. Since CD26 is a type II membrane protein with only six intracellular amino acids, it must deliver its signal via a signal-transducing molecule. Signaling is dependent on the expression of the T-cell receptor (TCR) complex with a special need for a functional zeta-chain....Continue Reading

References

Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P MoingeonE L Reinherz
Feb 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·G R FlentkeW W Bachovchin
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M F MoranT Pawson
Mar 30, 1989·Nature·M Reth
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T TanakaC Morimoto
Jan 1, 1995·European Journal of Immunology·H W MittrückerB Fleischer
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·T TanakaC Morimoto
Feb 1, 1993·Cellular Immunology·M HegenB Fleischer
Apr 1, 1994·Immunology Today·B Fleischer
Jun 1, 1994·Current Opinion in Immunology·T L CollinsS J Burakoff
Jan 28, 1994·Cell·A Weiss, D R Littman
Jan 1, 1993·Critical Reviews in Biochemistry and Molecular Biology·A Yaron, F Naider
Jan 1, 1996·The Journal of Experimental Medicine·G M BellJ B Imboden
Jan 1, 1996·Annual Review of Immunology·D J LenschowJ A Bluestone

❮ Previous
Next ❯

Citations

Feb 27, 2001·Medicinal Research Reviews·G CristalliE Camaioni
Feb 27, 2001·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·C AntczakB Bauvois
Apr 20, 2006·Modern Rheumatology·Kei OhnumaChikao Morimoto
Apr 23, 2003·Biochemical and Biophysical Research Communications·Kai LudwigChristoph Böttcher
Mar 31, 1999·Immunology Today·D RiemannJ Langner
Aug 4, 1999·Immunology Today·I De MeesterS Scharpé
Aug 17, 2002·Protein Expression and Purification·Jörg DobersHua Fan
Nov 9, 2002·Immunology·Kei OhnumaChikao Morimoto
Dec 21, 2004·Clinical and Experimental Immunology·C KruschinskiS von Hörsten
Apr 29, 1998·Immunological Reviews·J W Goding, M C Howard
Oct 13, 2001·Infection and Immunity·S U LeeG A Bohach
Jul 8, 2009·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Denise M T YuMark D Gorrell
Mar 1, 2000·Biochemical and Biophysical Research Communications·A Navarrete SantosD Riemann
Mar 4, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ismail KurtAlev Hasanoglu
Sep 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kei OhnumaChikao Morimoto
Jul 5, 2005·Expert Opinion on Investigational Drugs·J J Holst
Aug 24, 2007·Expert Opinion on Investigational Drugs·Charles Casey Cunningham
Aug 12, 2009·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Mark MerchantRodolfo Falconi
Jun 17, 2006·The Journal of Investigative Dermatology·Anja ThielitzHarald Gollnick
May 23, 2009·European Journal of Haematology·Stefano MolicaManlio Ferrarini
Jul 19, 2012·European Journal of Immunology·Ambak K RaiDipendra K Mitra
Jan 16, 2010·The FEBS Journal·Denise M T YuMark D Gorrell
Apr 11, 2003·Chemico-biological Interactions·Mark J Bailey, Ronald G Dickinson
Jul 13, 2004·Seminars in Cancer Biology·Jo Van DammeGhislain Opdenakker
Dec 20, 2003·Biochemical and Biophysical Research Communications·Kai LudwigChristoph Böttcher
Oct 26, 2005·The International Journal of Biochemistry & Cell Biology·Carolyn F Deacon, Jens J Holst
Aug 27, 2016·Clinical Reviews in Allergy & Immunology·Juan J Nieto-FontarigoFrancisco J Salgado

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.